AIDSWEEKLY Plus; Monday, April 10, 2000
Prepared by AIDS Weekly editors from staff and other reports

The model, described in the April 2000 issue of Nature Medicine, may result in breakthroughs such as barrier medications that prevent HIV from crossing through tissue linings of the female genital tract. Nat Med 2000 Apr;6(4):475-9

"The main route of HIV transmission has always been sexual, and heterosexuals are quickly becoming the largest HIV positive population, particularly in Third World countries," said researcher Phalguni Gupta, PhD, GSPH. "A model such as this is long overdue in understanding the virologic and host factors involved in HIV transmission in women."

According to Gupta, the new model will help researchers develop and test creams, suppositories or other medications to block the transmission of HIV.

Models used to date have demonstrated HIV transmission across a single layer of human cells grown specifically for that purpose. The new Pittsburgh model uses actual human tissue and thus closely mimics the stratified cell layers that are present at the sites of sexual transmission in women - the vagina and outer portion of the cervix.

"This model provides the natural tissue architecture of the female genital tract, including epithelial cells, submucosa, and immune cells, and it will allow us to effectively track transmission of HIV," said Gupta. It allows more rapid screening than did previous models, and by reducing the need for animals is more cost effective.

The new organ culture system involves placing a thumbnail-sized piece of squamous cervical tissue, with the epithelium layer on top, in the top chamber of a transwell device. HIV is added to the top of the tissue, and transmission of HIV is measured in the bottom chamber.

Scientists believe that the multilayer mucosal tissue structure of the female genital tract plays an important role in the sexual transmission of HIV. By allowing detailed study of the tissue structure, the model will enable researchers to determine which cells become infected initially, and how these cells interact with one another.

"The beauty of this model is that it allows us to test tissues from different areas of the human female genital organ to determine the role of each in transmission of HIV," said Gupta. In addition, tissue extracted at different stages of a woman's menstrual cycle can shed light on any effects hormonal and other changes might have on transmission.

Through further modification of the model scientists will be able to examine different genetic strains of HIV, as well as the effects of other sexually transmitted diseases on HIV transmission.

Using the new model, University of Pittsburgh researchers have already seen indications that cell-free virus is transmitted through the tissue structure much more efficiently than is cell-associated HIV, in which the virus remains inside a cell. Gupta and his colleagues are continuing research to further test these findings.

According to Gupta, plans also call for using the model to test rectal tissue in an effort to determine virologic and host factors in transmission between men.

This study was supported by the U.S. National Institutes of Health.

This article was prepared by AIDS Weekly editors from staff and other reports.

000410
AW000406

Copyright © 2000 - Charles Henderson, Publisher. All rights Reserved. Permission to reproduce granted to AEGIS by Charles W. Henderson. Authorization to reproduce for personal use granted granted by C. W. Henderson, Publisher, provided that the fee of US$4.50 per copy, per page is paid directly to the Copyright Clearance Center, 27 Congress Street, Salem, Massachusetts 01970, USA. Published by Charles Henderson, Publisher. Editorial & Publishing Office: P.O. Box 5528, Atlanta, GA 30307-0528 / Telephone: (800) 633-4931; Subscription Office: P.O. Box 830409, Birmingham, AL 35283-0409 / FAX: (205) 995-1588 http://www.newsrx.net

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1990, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.